A phase I study of TAK-659 and paclitaxel in patients with taxane-refractory advanced solid tumors.

被引：0
|
作者：
Gouda, Mohamed Alaa
Shunyakova, Jenny
Naing, Aung
Dumbrava, Ecaterina Elena
Hong, David S.
Yuan, Ying
Yang, Peiying
Myers, Alan
Liang, Yulong
Ping, Jing
Karp, Daniel D.
Tsimberidou, Apostolia Maria
Ahnert, Jordi Rodon
Yap, Timothy A.
Piha-Paul, Sarina A.
Meric-Bernstam, Funda
Fu, Siqing
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[2] Univ Missouri Kansas City, Sch Med, Kansas City, MO USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX USA
[5] Univ Texas Hlth Sci Ctr, Sch Dent, Dept Diagnost & Biomed Sci, Houston, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3152
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase I study of TAK-659 and paclitaxel in patients with taxane-refractory advanced solid tumors
    Gouda, M. A.
    Shunyakova, J.
    Naing, A.
    Dumbrava, E.
    Hong, D. S.
    Yuan, Y.
    Yang, P.
    Myers, A.
    Liang, Y.
    Peng, J.
    Karp, D.
    Tsimberidou, A. M.
    Rodon, J.
    Yap, T. A.
    Piha-Paul, S. A.
    Meric-Bernstam, F.
    Fu, S.
    ESMO OPEN, 2024, 9 (06)
  • [2] A phase 1b study to evaluate TAK-659 in combination with nivolumab in patients (pts) with advanced solid tumors.
    Juric, Dejan
    Faucette, Stephanie
    Wang, Ling
    Niu, Huifeng
    Kannan, Karuppiah
    Stump, Kate
    Rong, Yuanxin
    Shou, Yaping
    Nemunaitis, John J.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] Phase 1b study of TAK-659+nivolumab (nivo) in patients (pts) with advanced solid tumors.
    Juric, Dejan
    Olszanski, Anthony J.
    Vaishampayan, Ulka N.
    Li, Cong
    Wang, Shining
    Shou, Yaping
    Rong, Yuanxin
    Nemunaitis, John
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] Phase I study of olaparib in combination with carboplatin and/or paclitaxel in patients with advanced solid tumors.
    van der Noll, Ruud
    Ang, Joo Ern
    Jager, Agnes
    Marchetti, Serena
    Mergui-Roelvink, Marja
    De Bono, Johann Sebastian
    Lolkema, Martijn
    Brunetto, Andre
    Arkenau, Hendrik-Tobias
    De Jonge, Maja J.
    van der Biessen, Diane
    Tchakov, Ilian
    Bowen, Karin
    Schellens, Jan H. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [5] Phase I trial of daily imatinib mesylate and weekly paclitaxel in patients with advanced refractory solid tumors.
    Moore, DJ
    Bahrani, A
    Hwang, JJ
    Ramzi, P
    Marshall, JL
    JOURNAL OF INVESTIGATIVE MEDICINE, 2005, 53 (02) : S391 - S391
  • [6] POPULATION PHARMACOKINETICS OF TAK-659, AN INVESTIGATIONAL DUAL INHIBITOR OF SYK AND FLT-3, IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES OR SOLID TUMORS.
    Wang, S.
    Xiong, Y.
    Diderichsen, P. M.
    Miao, H.
    Venkatakrishnan, K.
    Gupta, N.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S115 - S115
  • [7] A phase I study of pazopanib with weekly paclitaxel and carboplatin in advanced solid tumors.
    Chan, Nancy
    Portal, Daniella E.
    Moss, Rebecca Anne
    Silk, Ann W.
    Stein, Mark N.
    Aisner, Joseph
    Malhotra, Jyoti
    Shih, Weichung
    Lin, Hongxia
    Kane, Michael P.
    Mehnert, Janice M.
    Tan, Antoinette R.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] Phase I clinical trial of daily imatinab mesylate (Gleevec) and weekly Paclitaxel in patients with advanced refractory solid tumors.
    Bahrani, A
    Hwang, J
    Egorm, MJ
    Barmen, P
    Ramzi, P
    Marshall, J
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6252S - 6252S
  • [9] Phase I study of sorafenib (S) with bevacizumab (B) and paclitaxel (P) in patients (pts) with refractory solid tumors.
    Chiorean, E. G.
    Matei, D.
    Younger, A.
    Funke, J. M.
    Waddell, M. J.
    Jones, D. R.
    Hahn, N. M.
    Perkins, S. M.
    Sandrasegaran, K.
    Sweeney, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] Phase I study of sapacitabine and seliciclib in patients with advanced solid tumors.
    Tolaney, Sara M.
    Hilton, John Frederick
    Cleary, James M.
    Gandhi, Leena
    Kwak, Eunice Lee
    Clark, Jeffrey W.
    Wolanski, Andrew
    Bell, Tracy Demeo
    Rodig, Scott J.
    Chiao, Judy H.
    Blake, David
    Shapiro, Geoffrey
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345